Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy

scientific article published on 27 July 2005

Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/RHEUMATOLOGY/KEI019
P698PubMed publication ID16049051
P5875ResearchGate publication ID7696756

P50authorGraham R. V. HughesQ73300356
Munther A. KhamashtaQ73418907
P2093author name stringM F Tungekar
D P D'Cruz
M Y Karim
C N Pisoni
L Ferro
I C Abbs
P433issue10
P304page(s)1317-1321
P577publication date2005-07-27
P1433published inRheumatologyQ7320492
P1476titleReduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy
P478volume44

Reverse relations

cites work (P2860)
Q37954539Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report
Q34490782Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis
Q36634248Emerging drug therapies for systemic lupus erythematosus
Q54365434Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population.
Q37754815Management of systemic lupus erythematosus in Chinese patients
Q37423758Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma
Q43248383Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Q37290624Mycophenolate mofetil in the treatment of lupus nephritis.
Q36458168Mycophenylate mofetil: what role in the treatment of lupus?
Q37146440Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy
Q38014716Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis?
Q21195423Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
Q34498515Systemic lupus erythematosus: review of synthetic drugs
Q46394345The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis
Q42728756Treatment of lupus nephritis
Q37690745Update on emerging drug therapies for systemic lupus erythematosus
Q37255744Update on the management of lupus nephritis: let the treatment fit the patient
Q36575376Update on the treatment of lupus nephritis

Search more.